Novabay Pharmaceuticals, INC. (NBY) SEC Filings — 2025
20 SEC filings for Novabay Pharmaceuticals, INC. (NBY) in 2025.
Filings
- NovaBay Pivots to Profit Amid Divestitures, Eyes Blockchain — 10-Q · Nov 7, 2025
- NovaBay Pharmaceuticals Files 8-K — 8-K · Oct 22, 2025
- NovaBay Pharmaceuticals Files 8-K — 8-K · Oct 21, 2025
- NovaBay Pharmaceuticals Files 8-K with Key Corporate Changes — 8-K · Oct 20, 2025
- NovaBay Pharmaceuticals Reports Board and Compensation Changes — 8-K · Oct 9, 2025
- NovaBay Pivots from Liquidation with $6M Lazar Investment, Seeks Major Shareholder Approvals — DEF 14A · Sep 23, 2025
- NovaBay Pharmaceuticals Files 8-K — 8-K · Sep 18, 2025
- NovaBay Pharmaceuticals Files 8-K — 8-K · Aug 26, 2025
- NovaBay Pharmaceuticals Reports Material Events — 8-K · Aug 19, 2025
- NovaBay Swings to Profit on Divestitures, Eyes Liquidation or New Strategy — 10-Q · Aug 14, 2025
- NovaBay Pharmaceuticals Q1 2025 Revenue at $5.5M — 10-Q · May 15, 2025
- NovaBay Pharmaceuticals Submits Matters to Security Holders — 8-K · Apr 22, 2025
- NovaBay Pharmaceuticals Files 2024 10-K — 10-K · Apr 2, 2025
- NovaBay Pharmaceuticals Files 2025 Proxy Statement — DEF 14A · Mar 19, 2025
- NovaBay Pharmaceuticals Enters Material Definitive Agreement — 8-K · Mar 11, 2025
- NovaBay Pharma Files Proxy Solicitation Material — DEFA14A · Mar 7, 2025
- NovaBay Pharma Files DEFA14A for Soliciting Material — DEFA14A · Feb 4, 2025
- NovaBay Sells Eyecare Business, Adjourns Shareholder Meeting — DEFA14A · Jan 23, 2025
- NovaBay Pharma CFO Departs, Interim Appointed; New Directors Elected — 8-K · Jan 22, 2025
- NovaBay Pharmaceuticals Completes Acquisition of 03 Life Sciences — 8-K · Jan 10, 2025